FDA Approves Zenbexus Combination for Multiple Myeloma

The FDA has approved Zenbexus (iberdomide) to treat adults with multiple myeloma. Multiple myeloma is a type of blood cancer that affects plasma cells in the bone marrow. It is used for people whose cancer… Read more

FDA Approves Pasatru for Adults With Rare Bone Disease

The FDA has approved Pasatru (garetosmab) for adults with fibrodysplasia ossificans progressiva (FOP). FOP is an ultra-rare genetic disease. It causes muscles, tendons, and ligaments to gradually turn into bone outside the normal skeleton. Over… Read more

FDA Approves Tudriqev for Advanced Skin Cancer

The FDA has approved Tudriqev (vusolimogene oderparepvec-wtpg) to treat adults with advanced skin cancer called cutaneous melanoma. It is used for cancer that cannot be removed by surgery and has gotten worse after treatment with… Read more

Headline: FDA Approves Gwyn Lo, a New Low-Dose Weekly Birth Control Patch

The FDA has approved Gwyn Lo (norelgestromin and ethinyl estradiol transdermal system).It is a new birth control skin patch for women who can get pregnant and have a body mass index (BMI) under 30. The… Read more

FDA Approves Lytenava Eye Injection for Wet Age-Related Macular Degeneration

Lytenava (bevacizumab) is now FDA approved to treat adults with neovascular age-related macular degeneration, which is also called wet AMD.Wet AMD is an eye disease that affects the center of your vision. It can cause… Read more

FDA Approves mFlusiva, the First mRNA Flu Vaccine for Older Adults

The FDA approved mFlusiva to help prevent the flu in adults ages 50 and older. The flu is a viral infection that affects the lungs and breathing airways. It causes a fever, body aches, and… Read more

FDA Approves Mucinex 12HR Cold & Fever Multi-Symptom for Cold and Flu Relief

What Is Mucinex 12HR Cold & Fever Multi-Symptom, and How Does It Work? The FDA has approved Mucinex 12HR Cold & Fever Multi-Symptom.It is an over-the-counter medicine used to relieve symptoms of the common cold… Read more

FDA Approves Pluvicto for Early-Stage Metastatic Prostate Cancer

The FDA has approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to treat adults with a specific type of advanced prostate cancer. It is used for prostate cancer that has spread to other parts of the… Read more

Tylenol With Naproxen: New Over-the-Counter Pill for 12-Hour Pain Relief

What Is Tylenol With Naproxen and How Does It Work? The FDA has approved a new combination product, Tylenol with Naproxen, for over-the-counter pain relief in adults and children 12 and older. It is approved… Read more

FDA Approves Simtriyo, a New Type of Stimulant, for Adults and Children With ADHD

The FDA has approved Simtriyo (centanafadine) to treat attention deficit hyperactivity disorder, also known as ADHD. It is approved for adults, as well as children who are 6 years of age and older and weigh… Read more